Siro could be a booster for BioconISI - Emerging Markets (subscription)Biocon will have much to gain from a possible alliance with clinical research organisation Siro Clinpharm. There is a buzz in the markets that the ...and more »

Indian markets open weakEquitymaster.comAs per a leading business daily, Biocon, through its clinical services arm Clinigene is exploring a tie up with a clinical research organisation SIRO ...

India Inc in News - January 27Myiris.comBiotechnology major Biocon`s clinical services arm Clingene is actively exploring an alliance with Mumbai-based clinical research organisation SIRO ...and more »

Biocon's Clingene, SIRO Clinpharm in alliance talksEconomic TimesBANGALORE: Biotechnology major Biocon's clinical services arm Clingene is actively exploring an alliance with Mumbai-based clinical research organisation ...and more »

Biocon and HCG Group of Hospitals Ltd. Join Hands to Fight against Cervical CancerBusiness Wire India (press release)... state of the art facilities as a big step towards developing India as a global destination for translational research and cutting edge clinical trials. ...and more »

Migrating to UC Platform Brought Gains for BioconInfoWorldThe company has five subsidiary companies in its stable: Syngene International, a custom research organization, Clinigene International, a clinical research ...and more »

Moneycontrol.comBiocon, Amylin Pharma tie up to develop new diabetes drugMoneycontrol.comBiocon will conduct research, trials and manufacture of the potential drug based on Amylin's 'phybrid' or peptide hybrid technology: the Amylin technology ...Biocon, US firm to jointly make drug for diabetesBombay NewsBiocon & Amylin Pharmaceuticals Join Hands For Anti-Diabetes Drugindia-server.comBiocon Seals Development, Commercialisation Agreement With AmylinPharmaceutical Business Reviewall 56 news articles »

Biocon inks pact with Amylin to develop diabetes therapyBusiness StandardBiocon would utilise its expertise to manufacture the compound and also leverage its experience in pre-clinical and clinical development of diabetes ...Biocon, Amylin Pharma tie up to develop new diabetes drugMoneycontrol.comBiocon, US firm to jointly make drug for diabetesBombay NewsBiocon & Amylin Pharmaceuticals Join Hands For Anti-Diabetes Drugindia-server.comPharmaceutical Business Reviewall 56 news articles »

Biocon's Q1 FY '10 Results Surge AheadBusiness Wire India (press release)Biocon, with its subsidiary companies form a fully integrated biotechnology enterprise, specializing in biopharmaceuticals, custom research, clinical ...and more »

Biocon, Bristol-Myers open R&D centreistockAnalyst.com (press release), OR... institutions (in India) through fellowships and partnerships to ensure … expertise in drug discovery and development sciences,” the release said quoting Dr Francis Cuss, BMS’ Senior Vice-President, Discovery and Exploratory Clinical Research. ...